Prostate cancer early diagnosis and treatment. korai diagnózis — Translation in English - TechDico


Az automatikus fordítás a megtekinthető a Google Fordító segítségével. A szolgáltatás biztosításáért nem vállalunk felelősséget, a fordított szöveget nem ellenőrizzük. Ha további segítségre van szüksége, lépjen kapcsolatba velünk. The proposed non-invasive blood test uses a combination of two techniques: surface-enhanced Raman scattering SERS and a new mathematical analysis technique called support vector machine SVM. Together, these techniques produce an accuracy up to

The current situation of cancer morbidity and mortality in the light of the National Cancer Registry, Hungary. Studies on prostatic cancer. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

mellékvese adenoma tünetei

Cancer Res. Treatment strategies for advanced prostate cancer. Actualities in the medical treatment of metastatic prostate cancer.

Novelties in diagnostics and treatment of prostate cancer.

melyik férfiaknak nincs prosztatitis

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer GETUG-AFU 15 : a randomised, open-label, phase 3 trial. Lancet Oncol. J Clin Oncol.

Fertőzéses keratitisek diagnosztikája és kezelése diagnostics and treatment of infectious keratitis Korai diagnózis felállításával és a megfelelő konzervatív kezelés mellett a fertőzéses keratitisek többsége sikeresen gyógyítható

Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer STAMPEDE : survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.

tabletták prosztatitis férfiakban

Lancet ; — Eur Urol. Ann Oncol.

Tabletták a prostatitis okar okára

Androgen receptor-mediated processes in castrate-resistant metastatic prostate cancer. Abiraterone and increased survival in metastatic prostate cancer.

The has a broad clinical and pre-clinical product pipeline. Our differentiated pipeline stands as proof of our ability to identify and address the areas of unmet treatment need and includes three Genmab-created antibodies, out-licensed and developed by partners, that were approved by the U. Food and Drug Administration with breakthrough designations—Daratumumab, Ofatumumab and Teprotumumab www. Our expertise allows the company to provide first-in-class immune-based diagnostic solutions to health care professionals but also execute biomarkers studies and companion diagnostic assay developed in conformity with regulations and in partnership with pharmaceuticals industries.

Abiraterone in metastatic prostate cancer without previous chemotherapy. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer.

PROSTATE CANCER SYMPTOMS - early and late stages; PROSTATE CANCER THERAPY

Abiraterone for prostate cancer not previously treated with hormone therapy. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.

The evolving landscape of metastatic hormone-sensitive prostate cancer: Epilepszia prosztata kezeléssel critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation.

Lehet a krónikus prosztatitis termelékenysége

Prostate Cancer Prostatic Dis.